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Objective. To establish the risk of carotid artery stent (CAS) complications in patients with aortic arch anomalies.
Methods. In a prospective series of patients submitted to CAS, all cases with arch anomalies were compared with cases
with normal arch anatomy (type I, II and III) in order to assess the impact of anatomic characteristics on technical and
clinical outcome. Outcome was evaluated in term of neurological complications and technical success.
Results. Of 214 consecutive patients undergoing CAS, 189 (88.3%) had normal arch anatomy and 25 (11.7%) arch anom-
alies. The arch abnormalities included common origin of brachiocephalic trunk and left common carotid artery in 22 cases
(10.2%), separate origin of right subclavian and common carotid in 2 cases (0.9%) and left common carotid agenesis with
separate arch origin of internal and external carotid in 1 case (0.5%). The two groups were not different in term of epide-
miology and preoperative clinical and morphological characteristics. Technical failure occurred overall in 26 cases (12%)
and neurological complication in 14 cases (6.5%). All symptoms were temporary. Technical failure was higher in the arch
anomaly group; however the difference did not reach statistical significance (89.6% vs 76.4%, P¼ 0.1). Neurological
complications occurred more frequently in the arch anomaly group (20% vs 5.3%, P¼ 0.039). Type of arch was the
only variable independently associated with neurological complications (OR¼ 2.01, p¼ 0.026).
Conclusion. Aortic arch anomalies are not infrequent and are associated with increased risk of neurological complications.
The indication for CAS should be carefully evaluated in these cases.
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It is known that complex aortic arch anatomy increases
the technical difficulties of carotid stent procedures
(CAS),1 and the risk of neurological complications,2
however data on the impact of arch anomalies on tech-
nical success and clinical outcome are sparse. Aortic
arch anomalies are not infrequent in the population.
Bovine arch,where theoriginof the left commoncarotid
artery is from the brachiocephalic trunk, is encountered
in 10%.3,4 We have analyzed a group of patients with
arch anomalies treated within our CAS program.
Material and Methods
In a prospective series of all patients submitted to CAS
fromDecember 2004 to July 2006 in a single institution,
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from the regular pattern were compared with normal
anatomy cases (type I, II and III arches). Groups
were compared in terms of epidemiology, clinical
and anatomical variables. Patients were submitted
to CAS according to current guidelines for carotid
stenting5 i.e., when an asymptomatic internal carotid
stenosis >80% or a symptomatic stenosis >50% was
found by duplex, using ECST duplex criteria.6
Complete inclusion and exclusion criteria utilized
are summarized in Table 1.
Description of CAS procedure. No pre-procedural
study of the supraortic vessels origin was performed
and all patients judged to be suitable for CAS were
taken to the angiographic suite following appropriate
informed consent and cardiological evaluation. CT or
MRI cerebral studies were performed in all cases. All
patients were medicated with aspirin 100 mg and clo-
pidogrel 75 mg for three days before the procedure.
All procedures were performed under local anaes-
thesia, with systemic heparinization and an 8F groinrved.
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achieved with a 40 degree Boston Scientific or
Medtronic HS I and II catheters over a terumo stiff
guidewire. When cannulation was not achievable by
these means, several different alternate techniques
were used (i.e., buddy wire, coaxial). Because of the
possibility of straightforward surgical intervention,
brachial or carotid access was not attempted in any
case. Routine cerebral protection was by Filterwire
EZ (Boston Scientific), Angioguard RX (Cordis) or
Accunet RX (Guidant) and stenting by Wallstent
(Boston Scientific), Precise (Cordis) or Acculink
(Guidant). ‘‘Technical success’’ was defined as place-
ment of the carotid stent with residual stenosis of less
than 30%. Neurological outcome was evaluated both
at the end of the procedure and in the next 24 hours.
Cases with either technical failure or neurological
complications were grouped under the term of ‘‘un-
satisfactory results’’ for the purpose of data analysis.
All patients submitted to angiography were consid-
ered in the analysis, regardless of arch anatomy,
plaque morphology and presence of proximal and
distal carotid tortuosity or disease. Therefore our
results represent also an estimate of the feasibility of
CAS in the population of patients over 70 years old.
Neurological, general and technical (duplex imaging)
outcome was evaluated at discharge and at 30 days,
6 months and yearly thereafter.
Data analysis. Univariate analyses were used to de-
scribe the study sample (Table 2) and the prevalence
Table 1. Inclusion and exclusion criteria in our series
Inclusion criteria
B Symptomatic CI lesion >50%
B Asymptomatic CI lesion >80%
B Age >70 years
B High surgical risk
Clinically significant cardiac disease (congestive heart
failure, abnormal stress test, or need for open-heart surgery)
Severe pulmonary disease
Contralateral laryngeal-nerve palsy
Previous radical neck surgery or radiation therapy to the neck
B Creatinine <2.0 mg
B One patent ileo-femoral artery
Exclusion criteria
B Recent disabling stroke with large (>1 cm) cerebral lesion
B Recent cerebral hemorrhage
B Presence of intraluminal thrombus
B Total occlusion of target vessel
B Aortic or biliateral iliac occlusion or previous bilateral
femoral arteries surgery
B History of significative bleeding disorder or coagulative
disorder
B Life expectancy <1 yr
B Degenerative cerebral disease with reduced collaborative
capacity
B Severe pulmonary with incapacity of maintain the supine
positionof complications. Continuous variables (age and per-
centage of stenosis) were also categorized and results
presented as percentages in addition to means and
standard deviation (SD). Differences in the prevalence
of complications according to each potential predictor
were first examined using Fisher’s exact test for cate-
gorical variables and Wilcoxon Rank-Sum test for con-
tinuous variables. Secondly, stepwise forward logistic
regression was used to examine the independent asso-
ciation between complications and each potential
determinant. The following criteria for the inclusion
of variables in the final model were adopted: clinical
relevance; p-value <0.2 and change in the odds ratio
of significant predictors greater than 10%. Standard
Table 2. List of preoperative variables considered in logistic
regression analysis
Gender
Male
Female
Age
65
66e75
76e85
>85
Aortic arch
Normal, type I
Normal, type II
Normal, type III
Abnormal
Plaque composition
Homogenous
Non-homogenous
Plaque surface
Ulcerated
Not-ulcerated
Contraletaral stenosis >80%
Yes
No
Contralateral occlusion
Yes
No
Stenosis
70%
75%
80%
>80%
Preoperative symptoms
Yes
No
Preoperative CT or RNM scan
Negative
Positive
Intraprocedure protection system
Concentric filter
Eccentric filter
Stent type
Nitinol
Chromium-cobaltEur J Vasc Endovasc Surg Vol 33, April 2007
438 G. L. Faggioli et al.Fig. 1. (a) Angiography and artist’s interpretation of Type I
bovine arch. The left common carotid artery origins from
the right brachiocephalic trunk, at top of aortic arch. (b) An-
giography and artist’s interpretation of Type II bovine arch.
The left common carotid artery origins from the right bra-
chiocephalic trunk, which arises below the top of the aortic
arch. (c) Angiography and artist’s interpretation of Type III
bovine arch. The left common carotid artery origins from the
right brachiocephalic trunk, which arises well below the top
of aortic arch.Eur J Vasc Endovasc Surg Vol 33, April 2007diagnostic procedures were adopted to check final
model validity: influential observation analysis (Dbeta,
change in Pearson chi-square and similar), multicolli-
nearity, interaction terms, Hosmer-Lemeshow test for
the goodness of fit and C statistic (area under the
Receiving Operator Curve). Statistical significance
was defined as a two-sided p-value <0.05, and all
analyses were carried out using STATA statistical
software, version 8.2 (Stata Corporation, College Station,
Texas, 2003).
Results
During the study period, 214 patients underwent CAS
and 95 patients were submitted to open surgery. On
214 consecutive patients undergoing CAS, 25 (11.6%)
were found to have arch anomalies: common origin
of brachiocephalic trunk and left common carotid
artery (so called bovine arch) in 22 cases (10.2%,
Fig. 1a, b and c), separate origin of right subclavian
and common carotid in 2 cases (0.9% Fig. 2) and left
common carotid agenesis with separate arch origin
of internal and external carotid in 1 case (0.5%
Fig. 3). The two groups were not different in term of
epidemiology and preoperative clinical and morpho-
logical characteristics (Table 3).
Technical failure occurred in 26 cases (12%) and
neurological complication in 14 cases (6.5%). All symp-
toms were not disabling and temporary (10 TIAs, 4
minor strokes, involving the ipsilateral hemisphere in
11 cases and the cerebellum in 3 cases). The complica-
tions occurred either during the procedure (specifically
during the phase of common carotid cannulation:
3 cases e 21%), from 2 to 8 hours after the procedure
(7 cases 50%) or more than 8 hours after the procedure
Fig. 2. Angiography and artist’s interpretation of a case of
separate origin of right subclavian and right common
carotid artery.
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more frequently in the arch anomaly group (20% vs
5.3%, P¼ 0.039). Technical failure was higher in the
arch anomaly group; however the difference did not
reach statistical significance (89.6% vs 76.4%, P¼ 0.1).
Type of archwas the only variable independently asso-
ciated with neurological complications (OR¼ 2.01,
p¼ 0.026). Technical failure was independently associ-
ated with arch anomaly (OR¼ 2.11, p¼ 0.005) and age
(OR1.14, p¼ 0.001) (Table 4).
A shown in Table 5, technical failures were mostly
due to tortuosity or angulations of the aortic arch and
of the common carotid artery. Although technical
failure and neurological complication rates slightly
decreased during the study period, no statistical dif-
ference was found in the results according to the
learning curve.
Mean follow-up was 11 7 months. An asymptom-
atic carotid occlusion was detected at 6 months in one
case in the normal arch group who experienced a car
accident 4 months after CAS. One patient died from
myocardial infarction at 4 months. No restenosis or
symptom recurrences occurred in this series.
Fig. 3. Angiography and artist’s interpretation of left
common carotid agenesia. The right internal and external
carotid arteries origin directly from the aortic arch.Discussion
Anatomical arch characteristics are known to influ-
ence results of CAS: arch elongation, presence of
calcification and diffuse disease of the origin of supra-
aortic vessels may increase procedural complications.
Arch anomalies further increase technical difficulties,
therefore leading to higher procedural risk.1,2 How-
ever no specific reports on CAS risk in the presence
of arch anomalies have been published so far. Our ex-
perience confirms the theoretical assumption that the
presence of an anomaly may increase both neurologi-
cal risk and technical failure rate, due to the greater
technical difficulty of the procedure. The presence of
an anomaly can be detected preoperatively; however
the technical problems can be evaluated with cer-
tainty, only when the procedure is in progress. Vessel
rigidity, presence of ostial plaques, underestimated
tortuosities can be a source of unexpected technical
challenge. All these characteristics are difficult to be
assessed by both CT scan and MRI. Clearly, the pres-
ence of an anomaly requires technical skills and spe-
cific devices. We have encountered several type of
anomaly. Common carotid agenesis is exceedingly
rare (5 cases have been reported in the literature so
far).7 The separate origin of the right subclavian and
common carotid is also very uncommon.8 However
these two anomalies were successfully treated in this
series. The bovine arch, which is more frequent and
occurs in as much as 10% of patients, was associated
with increased failure and neurological complication
rate. Despite the use of dedicated endovascular tools
and increasing radiological experience, when a bovine
arch was encountered, technical difficulties were
found to be very challenging, even after the accom-
plishment of the learning curve. It remains to be
explained what the mechanism of delayed onset of
neurological complications in most instances and the
role of arch anomalies in this regard. We can only
speculate that difficult arch cannulation withTable 3. Epidemiology and preoperative clinical and morphological characteristics
Normal arch (total 189 cases) Arch anomalies (total 25 cases) P
Age (yr) Mean SD 76.08 (6.65SD) 79.88 (9.53SD)
Male sex 119 (62.9%) 13 (52%) 0.38
Hypertension 159 (84%) 23 (92%) 0.38
Diabetes mellitus 47 (24.8%) 8 (32%) 0.46
Dyslipidemia 64 (33.8%) 10 (40%) 0.65
Coronary artery disease 69 (36.5%) 12 (48%) 0.27
Renal insufficiency 22 (11.6%) 4 (16%) 0.51
Chronic obstructive pulmonary disease 49 (25.9%) 4 (16%) 0.33
Current smoking 21 (11%) 2 (8%) 1
Symptoms 43 (22.7%) 6 (24%) 0.60
Type of plaque: non-homogeneus 41 (21.6%) 3 (12%) 0.42
Type of plaque: ulcerated 17 (8.9%) 2 (8%) 1Eur J Vasc Endovasc Surg Vol 33, April 2007
440 G. L. Faggioli et al.Table 4. Results of the logistic regression model predicting neurological complications and technical insuccess
Variables Neurological complications Technical insuccess
Adjusted OR (95% CI)a pb Adjusted OR (95% CI)a pb
Age (1-year increment) 1.03 (0.94e1.12) 0.5 1.14 (1.05e1.23) 0.001
Arch (anomaly versus others) 2.01 (1.09e3.71) 0.026 2.11 (1.25e3.56) 0.005
a An odds ratio> 1 indicates a higher likelihood of technical failure. Model parameters: LR chi-2¼ 5.2.
b Hosmer-Lemeshow goodness-of-fit p¼ 0.81; area under the ROC curve¼ 0.63.extensive manoeuvres can disrupt aortic plaques with
subsequent delayed dislodgment. This speculation
finds support in the findings of embolization in the
contralateral hemisphere in different reports and in
our own experience (unpublished data).
Rate of technical failure remained high in this
group even in the more recent procedures. The results
obtained in this series deserve some consideration,
since they may seem suboptimal in term of success
rate. It is our policy to submit to CAS all patients
with indication for carotid revascularization (i.e.
symptomatic carotid stenosis >50% or asymptomatic
carotid stenosis >80%), after appropriate informed
consent if no contraindication to the procedure are
present or if the patient is particularly young. In this
regard the technical success rate of type I and II arches
is 97% in the last 70 cases of our series. The fact that
age was significantly associated with failure rate in
our series is easily explained by the increased vessel
elongation over time, thus determining more difficult
anatomic characteristics, both in the arch and in the
carotid vessels.
Other authors have reported overall higher rates of
success in CAS procedures (up to 99.5%)1,9,10 however
it is not known if some kind of anatomical selection
was performed in these series. As a matter of fact, pa-
tients with ‘‘carotid tortuosity’’ were excluded in one
series10 and direct carotid access was performed in 5/
190 (2.6%) cases in another.1 In our practice we elected
to avoid cervical and brachial access for a variety of
reasons, i.e. inadequate instrumentation in the angio
suite, risk of peripheral complication, possibility of
offering surgical procedure with mortality-morbidity
risk <1%), thus our rate of success in this series
should be read as ‘‘transfemoral success rate’’. Neuro-
logical complications were only mild and temporary
Table 5. Causes of technical insuccess in this series
Tortuosity or angulation of aortic arch/common carotid 19
Uncrossable carotid stenosis 4
Heavy plaque calcification 1
Uncooperative patient 1
Filter entrapment within stent struts 1
Total 26Eur J Vasc Endovasc Surg Vol 33, April 2007in our experience, but demonstrate an increased risk
of cerebral embolization in the presence of complex
arch anatomy. The importance of carotid cannulation
in determining distal embolization has been empha-
sized by several authors11e15 and our results confirm
these findings.
In conclusion, until definitive evidence on the role of
CAS in stroke prevention becomes available, the pres-
ence of an aortic arch anomaly should caution the less
experienced vascular surgeon to avoid strenuous at-
tempts to accomplish the CAS procedure. Moreover,
in the presence of arch anomalies CAS should be
reserved for patients with high surgical risk.
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